Screener
Bio-Techne TECH Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Nine months ended March 31, 2026 | Common Stock / Shares | Common Stock / Amount | Additional / Paid-in / Capital | Retained / Earnings | Accumulated / Other / Comprehensive / Loss | Total |
|---|---|---|---|---|---|---|
| Stock-based compensation expense | 13,727 | 13,727 | ||||
| Employee stock purchase plan expense | 373 | 373 | ||||
| Balances at December 31, 2025 | 155,881 | $1,559 | $964,955 | $1,106,819 | $(62,344) | $2,010,989 |
| Net earnings | 51,047 | 51,047 | ||||
| Other comprehensive income | (4,512) | (4,512) | ||||
| Common stock issued for exercise of options | 589 | 6 | 28,056 | — | 28,062 | |
| Common stock issued for restricted stock awards | 4 | 0 | 0 | (156) | (156) | |
| Cash dividends ($0.08 per share) | (12,518) | (12,518) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's net income?
- Bio-Techne (TECH) reported net income of $51.05M in Q1 2026.
- How has Bio-Techne's net income changed year-over-year?
- Bio-Techne's net income increased by 126.0% year-over-year, from $22.59M to $51.05M.
- What is the long-term trend for Bio-Techne's net income?
- Over 2 years (2022 to 2024), Bio-Techne's net income has grown at a -20.1% compound annual growth rate (CAGR), from $263.1M to $168.11M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Bio-Techne's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude